Tural, D. Et Al. 2022. Long-term outcome and safety in patients treated with immune checkpoint blockade therapies for urothelial carcinoma: Experience from real-world clinical practice.. JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.6 .

Tural, D., Arslan, C., Selcukbiricik, F., Olmez, O. F., Erman, M., Urun, Y., ... Karadurmus, N.(2022). Long-term outcome and safety in patients treated with immune checkpoint blockade therapies for urothelial carcinoma: Experience from real-world clinical practice.. JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.6.

Tural, Deniz Et Al. "Long-term outcome and safety in patients treated with immune checkpoint blockade therapies for urothelial carcinoma: Experience from real-world clinical practice.," JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.6, 2022

Tural, Deniz Et Al. "Long-term outcome and safety in patients treated with immune checkpoint blockade therapies for urothelial carcinoma: Experience from real-world clinical practice.." JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.6, 2022

Tural, D. Et Al. (2022) . "Long-term outcome and safety in patients treated with immune checkpoint blockade therapies for urothelial carcinoma: Experience from real-world clinical practice.." JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.6.

@article{article, author={Deniz Tural Et Al. }, title={Long-term outcome and safety in patients treated with immune checkpoint blockade therapies for urothelial carcinoma: Experience from real-world clinical practice.}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2022}